{"id":354038,"date":"2025-08-28T10:35:23","date_gmt":"2025-08-28T10:35:23","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-charles-river-laboratories-international\/"},"modified":"2025-08-28T10:35:23","modified_gmt":"2025-08-28T10:35:23","slug":"how-to-buy-charles-river-laboratories-international","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","title":{"rendered":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354038","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Charles River Laboratories International (CRL) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Charles River Laboratories International (CRL) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"FDA onayl\u0131 ila\u00e7lar\u0131n %80'ine dokunan bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Charles River Laboratories (CRL), modern t\u0131bb\u0131n g\u00f6r\u00fcnmez omurgas\u0131d\u0131r\u2014ila\u00e7 devlerinin hayat kurtaran tedavileri piyasaya sunmas\u0131na yard\u0131mc\u0131 olan bir s\u00f6zle\u015fmeli ara\u015ft\u0131rma organizasyonu. Bu sadece ba\u015fka bir hisse senedi de\u011fil; sa\u011fl\u0131k inovasyonunun gelece\u011fine bir payd\u0131r.","intro_source":{"label":"Intro","type":"text","formatted_value":"FDA onayl\u0131 ila\u00e7lar\u0131n %80'ine dokunan bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Charles River Laboratories (CRL), modern t\u0131bb\u0131n g\u00f6r\u00fcnmez omurgas\u0131d\u0131r\u2014ila\u00e7 devlerinin hayat kurtaran tedavileri piyasaya sunmas\u0131na yard\u0131mc\u0131 olan bir s\u00f6zle\u015fmeli ara\u015ft\u0131rma organizasyonu. Bu sadece ba\u015fka bir hisse senedi de\u011fil; sa\u011fl\u0131k inovasyonunun gelece\u011fine bir payd\u0131r."},"body_html":"<h2>\ud83d\udcc8 CRL Hisse Analizi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla Charles River Laboratories International (CRL), NYSE'de <strong>159,58 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. \u015eirket, beklenen 2,50 $'a kar\u015f\u0131l\u0131k 3,12 $ EPS ile m\u00fckemmel bir 2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi a\u00e7\u0131klad\u0131\u2014%24,80'lik b\u00fcy\u00fck bir s\u00fcrpriz, hisse senetlerinin \u00f6n piyasa i\u015flemlerinde %4 y\u00fckselmesine neden oldu.<\/p> <p><strong>Takviminize Not Edin: 5 Kas\u0131m 2025<\/strong><br> Bu sizin bir sonraki kritik tarihiniz. Charles River, piyasa a\u00e7\u0131lmadan \u00f6nce 2025 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 raporlayacak. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketleri yarat\u0131r. Son sefer ne oldu, bak\u0131n:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>6 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>155,00 $<\/td><td>+%4 (an\u0131nda)<\/td><\/tr> <tr><td>8 May\u0131s 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>148,50 $<\/td><td>+%3,2 (hafta)<\/td><\/tr> <tr><td>\u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>142,00 $<\/td><td>+%5,8 (beklenti \u00fcst\u00fc)<\/td><\/tr> <tr><td>Kas 2024<\/td><td>Ortakl\u0131k Haberi<\/td><td>138,75 $<\/td><td>+%4,1 (3 g\u00fcn)<\/td><\/tr> <tr><td>A\u011fu 2024<\/td><td>2. \u00c7eyrek 2024<\/td><td>135,20 $<\/td><td>-%2,9 (beklenti alt\u0131)<\/td><\/tr> <\/tbody> <\/table> <p>Desen a\u00e7\u0131k: pozitif kazan\u00e7 s\u00fcrprizleri an\u0131nda kazan\u00e7 sa\u011flarken, beklenti alt\u0131 sonu\u00e7lar sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in al\u0131m f\u0131rsatlar\u0131 yarat\u0131yor.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2> <p>CRL son alt\u0131 ayda olduk\u00e7a hareketliydi:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: 142,00 $ (tatil sonras\u0131 istikrar)<\/li> <li><strong>Mart 2025<\/strong>: 136,50 $ (FDA d\u00fczenleme endi\u015feleri)<\/li> <li><strong>Nisan 2025<\/strong>: 148,00 $ (%6,81 art\u0131\u015f ara\u015ft\u0131rma haberiyle)<\/li> <li><strong>May\u0131s 2025<\/strong>: 152,75 $ (1. \u00e7eyrek kazan\u00e7 ivmesi)<\/li> <li><strong>Temmuz 2025<\/strong>: 157,20 $ (yaz konsolidasyonu)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 159,58 $ (2. \u00e7eyrek kazan\u00e7 art\u0131\u015f\u0131)<\/li> <\/ul> <p>Bu, alt\u0131 ayda <strong>%12,4 kazan\u00e7<\/strong> demek\u2014muhte\u015fem de\u011fil ama sekt\u00f6r zorluklar\u0131na ra\u011fmen istikrarl\u0131 b\u00fcy\u00fcme. Hisse, FDA'n\u0131n hayvan testlerini azaltma planlar\u0131n\u0131n yat\u0131r\u0131mc\u0131lar\u0131 korkuttu\u011fu Mart diplerinden toparlanma g\u00f6sterdi.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 175-190 $ (mevcut fiyattan %10-19 art\u0131\u015f)<br> <em>Neden: G\u00fc\u00e7l\u00fc s\u00f6zle\u015fme ak\u0131\u015f\u0131 + y\u00fckseltilmi\u015f kar rehberi<\/em><\/li> <li><strong>2026 Hedefi<\/strong>: 200-225 $ (%25-41 b\u00fcy\u00fcme potansiyeli)<br> <em>Neden: Piyasa toparlanmas\u0131 + geni\u015fletilmi\u015f hizmet teklifleri<\/em><\/li> <li><strong>2028 Projeksiyonu<\/strong>: 280-320 $ (%75-100 uzun vadeli kazan\u00e7)<br> <em>Neden: Biyoteknoloji patlamas\u0131 + ya\u015flanan n\u00fcfus talebi<\/em><\/li> <li><strong>2030 Vizyonu<\/strong>: 400-450 $ (%150-180 toplam getiri)<br> <em>Neden: K\u00fcresel sa\u011fl\u0131k geni\u015flemesi + yapay zeka entegrasyonu<\/em><\/li> <\/ul> <p><strong>Karar: UZUN VADEL\u0130 YATIRIMCILAR \u0130\u00c7\u0130N G\u00dc\u00c7L\u00dc ALIM<\/strong>. Son kazan\u00e7 s\u00fcrprizi ve y\u00fckseltilmi\u015f rehberlik, k\u0131sa vadeli dalgalanmalara ra\u011fmen y\u00f6netim g\u00fcvenini g\u00f6steriyor.<\/p>  <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2> <ul> <li><strong>D\u00fczenleyici Riskler<\/strong>: FDA'n\u0131n hayvan testlerini azaltma plan\u0131, Ke\u015fif ve G\u00fcvenlik De\u011ferlendirme segmentinden elde edilen gelirin %30'unu etkileyebilir. Bu varsay\u0131msal de\u011fil\u2014zaten analist not d\u00fc\u015f\u00fc\u015flerine neden oluyor.<\/li> <li><strong>M\u00fc\u015fteri Konsantrasyonu<\/strong>: B\u00fcy\u00fck ila\u00e7 \u015firketlerinin b\u00fct\u00e7e kesintileri veya birle\u015fmeleri s\u00f6zle\u015fme hacimlerini azaltabilir. B\u00fcy\u00fck ila\u00e7 hap\u015f\u0131rd\u0131\u011f\u0131nda, CRO'lar so\u011fuk alg\u0131nl\u0131\u011f\u0131 kapar.<\/li> <li><strong>D\u00f6viz Riski<\/strong>: Gelirin %68'i yurtd\u0131\u015f\u0131ndan geldi\u011fi i\u00e7in g\u00fc\u00e7l\u00fc dolar uluslararas\u0131 k\u00e2rlar\u0131 olumsuz etkiler.<\/li> <li><strong>Bor\u00e7 Endi\u015feleri<\/strong>: 2,1 milyar $ bor\u00e7 y\u00fck\u00fc, ekonomik belirsizlikte nakit ak\u0131\u015f\u0131 y\u00f6netimini gerektirir.<\/li> <\/ul>  <h2>\ud83d\udfe2 Pozitif Sinyaller: Neden CRL Y\u00fckselebilir<\/h2> <ul> <li><strong>Kazan\u00e7 \u0130vmelenmesi<\/strong>: 2025 2. \u00e7eyrek %24,80 s\u00fcrprizi operasyonel m\u00fckemmelli\u011fi g\u00f6steriyor<\/li> <li><strong>S\u00f6zle\u015fme Kazan\u0131mlar\u0131<\/strong>: K\u00fcresel biyofarma m\u00fc\u015fterileriyle \u00e7ok say\u0131da b\u00fcy\u00fck \u00f6l\u00e7ekli yenileme<\/li> <li><strong>Sekt\u00f6r Trendi<\/strong>: D\u0131\u015f kaynakl\u0131 ara\u015ft\u0131rmalar y\u0131ll\u0131k %8 b\u00fcy\u00fcyor, \u00e7\u00fcnk\u00fc ila\u00e7 \u015firketleri maliyetleri k\u0131s\u0131yor<\/li> <li><strong>Dijital D\u00f6n\u00fc\u015f\u00fcm<\/strong>: Laboratuvar otomasyonu yat\u0131r\u0131mlar\u0131 marjlar\u0131 iyile\u015ftiriyor<\/li> <li><strong>Savunmac\u0131 \u0130\u015f Modeli<\/strong>: Ekonomik ko\u015fullardan ba\u011f\u0131ms\u0131z olarak temel hizmetler<\/li> <\/ul>  <h2>\ud83d\udcf0 Son Haberlerin Etkisi: A\u011fustos 2025 Analizi<\/h2> <p>Charles River 2025'te olduk\u00e7a hareketli! \u015eirket, geli\u015fmi\u015f ila\u00e7 geli\u015ftirme modelleri geli\u015ftirmek i\u00e7in \u00f6nde gelen bir biyoteknoloji firmas\u0131yla geni\u015fletilmi\u015f i\u015f birli\u011fi dahil olmak \u00fczere birka\u00e7 stratejik ortakl\u0131k sa\u011flad\u0131. Bu anla\u015fmalar sadece bas\u0131n b\u00fclteni de\u011fil\u2014y\u0131llarca b\u00fcy\u00fcmeyi destekleyebilecek gelecekteki gelir ak\u0131\u015flar\u0131n\u0131 temsil ediyor.<\/p> <p>En \u00f6nemlisi, y\u00f6netim makroekonomik zorluklara ra\u011fmen tam y\u0131l rehberli\u011fini teyit etti. Y\u00f6neticiler belirsiz zamanlarda tahminlerinin arkas\u0131nda durdu\u011funda, bu genellikle iyi bir i\u015farettir.<\/p>  <h2>\ud83c\udfaf Yeni Ba\u015flayanlar \u0130\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: A\u015f\u0131r\u0131 maruz kalmadan oyuna girmek i\u00e7in 1-2 hisse al\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Fiyat dalgalanmalar\u0131na bakmadan ayl\u0131k 100 $ ekleyin<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Hisse 150 $ destek seviyesine d\u00fc\u015ferse daha fazla al\u0131n<\/li> <li><strong>Sab\u0131r \u00d6d\u00fcllendirir<\/strong>: Bu 3-5 y\u0131ll\u0131k bir yat\u0131r\u0131m, haftal\u0131k ticaret de\u011fil<\/li> <li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: \"CRL ticareti, boya kurumas\u0131n\u0131 izlemek gibidir\u2014ta ki aniden bir ba\u015fyap\u0131t olana kadar. At\u0131\u015ft\u0131rmal\u0131k getirin.\"<\/li> <\/ol>  <h2>\u2705 Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ticaret Platformu Se\u00e7in<\/td><td>NYSE hisseleri ve kesirli paylar sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Denemek i\u00e7in 50-100 $ ile ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"CRL\" Aray\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Daha iyi giri\u015f i\u00e7in 158-161 $ civar\u0131nda limit emri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Ger\u00e7ekle\u015ftirin<\/td><td>Komisyon \u00fccretlerini kontrol edin\u2014%1'in alt\u0131nda i\u015flem maliyeti hedefleyin<\/td><\/tr> <tr><td>6<\/td><td>Portf\u00f6y Da\u011f\u0131l\u0131m\u0131n\u0131 Ayarlay\u0131n<\/td><td>\u00c7e\u015fitlendirme i\u00e7in CRL'yi toplam portf\u00f6y\u00fcn %5-10'u aras\u0131nda tutun<\/td><\/tr> <tr><td>7<\/td><td>Fiyat Uyar\u0131lar\u0131n\u0131 Etkinle\u015ftirin<\/td><td>\u00d6nemli destek\/diren\u00e7 seviyelerinde bildirim al\u0131n<\/td><\/tr> <tr><td>8<\/td><td>Tezinizi Belgeleyin<\/td><td>Gelecek referans i\u00e7in neden ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n<\/td><\/tr> <tr><td>9<\/td><td>D\u00fczenli \u0130nceleme Yap\u0131n<\/td><td>G\u00fcnl\u00fck fiyat hareketleri de\u011fil, \u00e7eyreklik kazan\u00e7lar\u0131 kontrol edin<\/td><\/tr> <tr><td>10<\/td><td>Temett\u00fcleri Yeniden Yat\u0131r\u0131n<\/td><td>CRL temett\u00fc \u00f6demez, ancak bile\u015fik b\u00fcy\u00fcme planlay\u0131n<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Pocket Option, CRL Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Neden Mant\u0131kl\u0131?<\/h2> <p>Pocket Option, Charles River Laboratories yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> - K\u00fc\u00e7\u00fck pozisyonlarla stratejileri test etmek i\u00e7in ideal<\/li> <li><strong>Y\u0131ld\u0131r\u0131m H\u0131z\u0131nda KYC<\/strong> - Herhangi bir kimlik belgesini y\u00fckleyin ve dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>100+ Para \u00c7ekme Y\u00f6ntemi<\/strong> - Kripto, e-c\u00fczdanlar, banka kartlar\u0131\u2014k\u00e2r\u0131n\u0131z, sizin se\u00e7iminiz<\/li> <li><strong>Kesirli Hisseler Mevcut<\/strong> - CRL'nin tam hisse fiyat\u0131 olmadan par\u00e7alar\u0131n\u0131 sat\u0131n al\u0131n<\/li> <li><strong>Ger\u00e7ek Zamanl\u0131 NYSE Verisi<\/strong> - Bilin\u00e7li kararlar i\u00e7in do\u011fru fiyatland\u0131rma<\/li> <\/ul> <p>Yeni yat\u0131r\u0131mc\u0131lar i\u00e7in bu eri\u015filebilirlik, binlerce dolar \u00f6nceden gerekmeden CRL'de kademeli pozisyon olu\u015fturman\u0131z\u0131 sa\u011flar.<\/p>  <h2>\ud83c\udf0d 2025'te Charles River Laboratories: G\u00f6r\u00fcnmez \u0130la\u00e7 Devi<\/h2> <p>Charles River, herkesin bildi\u011fi bir isim de\u011fil ama olmal\u0131. Bu \u015firket, son be\u015f y\u0131lda <strong>FDA onayl\u0131 ila\u00e7lar\u0131n %80'inde<\/strong> yer ald\u0131\u2014bu, hastalara ula\u015fan hemen hemen her b\u00fcy\u00fck ila\u00e7 demek. 1947'de kurulan CRL, hayvan ara\u015ft\u0131rma sa\u011flay\u0131c\u0131s\u0131ndan, d\u00fcnya \u00e7ap\u0131nda ila\u00e7 devlerine hizmet veren kapsaml\u0131 bir ila\u00e7 geli\u015ftirme orta\u011f\u0131na evrildi.<\/p> <p>\u015eirket \u00fc\u00e7 ana segmentte faaliyet g\u00f6steriyor: Ara\u015ft\u0131rma Modelleri ve Hizmetleri, Ke\u015fif ve G\u00fcvenlik De\u011ferlendirmesi ve \u00dcretim Deste\u011fi. 20.100 \u00e7al\u0131\u015fan\u0131, kanserden nadir hastal\u0131klara kadar tedavileri h\u0131zland\u0131rmak i\u00e7in k\u00fcresel laboratuvarlarda \u00e7al\u0131\u015f\u0131yor.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Charles River'\u0131n bilim insanlar\u0131, bile\u015fik etkinli\u011fini %92 do\u011frulukla tahmin edebilen yapay zeka destekli \u00e7\u0131\u011f\u0131r a\u00e7an bir ila\u00e7 ke\u015fif platformu geli\u015ftirdi\u2014ara\u015ft\u0131rma s\u00fcresini y\u0131llardan aylara indiriyor ve geli\u015ftirme maliyetlerinde milyarlarca dolar tasarruf potansiyeli sunuyor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 CRL Hisse Analizi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla Charles River Laboratories International (CRL), NYSE&#8217;de <strong>159,58 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. \u015eirket, beklenen 2,50 $&#8217;a kar\u015f\u0131l\u0131k 3,12 $ EPS ile m\u00fckemmel bir 2. \u00e7eyrek kazan\u00e7 s\u00fcrprizi a\u00e7\u0131klad\u0131\u2014%24,80&#8217;lik b\u00fcy\u00fck bir s\u00fcrpriz, hisse senetlerinin \u00f6n piyasa i\u015flemlerinde %4 y\u00fckselmesine neden oldu.<\/p>\n<p><strong>Takviminize Not Edin: 5 Kas\u0131m 2025<\/strong><br \/> Bu sizin bir sonraki kritik tarihiniz. Charles River, piyasa a\u00e7\u0131lmadan \u00f6nce 2025 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 raporlayacak. Tarihsel olarak, bu raporlar \u00f6nemli fiyat hareketleri yarat\u0131r. Son sefer ne oldu, bak\u0131n:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>6 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>155,00 $<\/td>\n<td>+%4 (an\u0131nda)<\/td>\n<\/tr>\n<tr>\n<td>8 May\u0131s 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>148,50 $<\/td>\n<td>+%3,2 (hafta)<\/td>\n<\/tr>\n<tr>\n<td>\u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>142,00 $<\/td>\n<td>+%5,8 (beklenti \u00fcst\u00fc)<\/td>\n<\/tr>\n<tr>\n<td>Kas 2024<\/td>\n<td>Ortakl\u0131k Haberi<\/td>\n<td>138,75 $<\/td>\n<td>+%4,1 (3 g\u00fcn)<\/td>\n<\/tr>\n<tr>\n<td>A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>135,20 $<\/td>\n<td>-%2,9 (beklenti alt\u0131)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Desen a\u00e7\u0131k: pozitif kazan\u00e7 s\u00fcrprizleri an\u0131nda kazan\u00e7 sa\u011flarken, beklenti alt\u0131 sonu\u00e7lar sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in al\u0131m f\u0131rsatlar\u0131 yarat\u0131yor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ama\u00e7l\u0131 Bir Rollercoaster<\/h2>\n<p>CRL son alt\u0131 ayda olduk\u00e7a hareketliydi:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: 142,00 $ (tatil sonras\u0131 istikrar)<\/li>\n<li><strong>Mart 2025<\/strong>: 136,50 $ (FDA d\u00fczenleme endi\u015feleri)<\/li>\n<li><strong>Nisan 2025<\/strong>: 148,00 $ (%6,81 art\u0131\u015f ara\u015ft\u0131rma haberiyle)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 152,75 $ (1. \u00e7eyrek kazan\u00e7 ivmesi)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 157,20 $ (yaz konsolidasyonu)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 159,58 $ (2. \u00e7eyrek kazan\u00e7 art\u0131\u015f\u0131)<\/li>\n<\/ul>\n<p>Bu, alt\u0131 ayda <strong>%12,4 kazan\u00e7<\/strong> demek\u2014muhte\u015fem de\u011fil ama sekt\u00f6r zorluklar\u0131na ra\u011fmen istikrarl\u0131 b\u00fcy\u00fcme. Hisse, FDA&#8217;n\u0131n hayvan testlerini azaltma planlar\u0131n\u0131n yat\u0131r\u0131mc\u0131lar\u0131 korkuttu\u011fu Mart diplerinden toparlanma g\u00f6sterdi.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 175-190 $ (mevcut fiyattan %10-19 art\u0131\u015f)<br \/> <em>Neden: G\u00fc\u00e7l\u00fc s\u00f6zle\u015fme ak\u0131\u015f\u0131 + y\u00fckseltilmi\u015f kar rehberi<\/em><\/li>\n<li><strong>2026 Hedefi<\/strong>: 200-225 $ (%25-41 b\u00fcy\u00fcme potansiyeli)<br \/> <em>Neden: Piyasa toparlanmas\u0131 + geni\u015fletilmi\u015f hizmet teklifleri<\/em><\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 280-320 $ (%75-100 uzun vadeli kazan\u00e7)<br \/> <em>Neden: Biyoteknoloji patlamas\u0131 + ya\u015flanan n\u00fcfus talebi<\/em><\/li>\n<li><strong>2030 Vizyonu<\/strong>: 400-450 $ (%150-180 toplam getiri)<br \/> <em>Neden: K\u00fcresel sa\u011fl\u0131k geni\u015flemesi + yapay zeka entegrasyonu<\/em><\/li>\n<\/ul>\n<p><strong>Karar: UZUN VADEL\u0130 YATIRIMCILAR \u0130\u00c7\u0130N G\u00dc\u00c7L\u00dc ALIM<\/strong>. Son kazan\u00e7 s\u00fcrprizi ve y\u00fckseltilmi\u015f rehberlik, k\u0131sa vadeli dalgalanmalara ra\u011fmen y\u00f6netim g\u00fcvenini g\u00f6steriyor.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Neler Yanl\u0131\u015f Gidebilir?<\/h2>\n<ul>\n<li><strong>D\u00fczenleyici Riskler<\/strong>: FDA&#8217;n\u0131n hayvan testlerini azaltma plan\u0131, Ke\u015fif ve G\u00fcvenlik De\u011ferlendirme segmentinden elde edilen gelirin %30&#8217;unu etkileyebilir. Bu varsay\u0131msal de\u011fil\u2014zaten analist not d\u00fc\u015f\u00fc\u015flerine neden oluyor.<\/li>\n<li><strong>M\u00fc\u015fteri Konsantrasyonu<\/strong>: B\u00fcy\u00fck ila\u00e7 \u015firketlerinin b\u00fct\u00e7e kesintileri veya birle\u015fmeleri s\u00f6zle\u015fme hacimlerini azaltabilir. B\u00fcy\u00fck ila\u00e7 hap\u015f\u0131rd\u0131\u011f\u0131nda, CRO&#8217;lar so\u011fuk alg\u0131nl\u0131\u011f\u0131 kapar.<\/li>\n<li><strong>D\u00f6viz Riski<\/strong>: Gelirin %68&#8217;i yurtd\u0131\u015f\u0131ndan geldi\u011fi i\u00e7in g\u00fc\u00e7l\u00fc dolar uluslararas\u0131 k\u00e2rlar\u0131 olumsuz etkiler.<\/li>\n<li><strong>Bor\u00e7 Endi\u015feleri<\/strong>: 2,1 milyar $ bor\u00e7 y\u00fck\u00fc, ekonomik belirsizlikte nakit ak\u0131\u015f\u0131 y\u00f6netimini gerektirir.<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Pozitif Sinyaller: Neden CRL Y\u00fckselebilir<\/h2>\n<ul>\n<li><strong>Kazan\u00e7 \u0130vmelenmesi<\/strong>: 2025 2. \u00e7eyrek %24,80 s\u00fcrprizi operasyonel m\u00fckemmelli\u011fi g\u00f6steriyor<\/li>\n<li><strong>S\u00f6zle\u015fme Kazan\u0131mlar\u0131<\/strong>: K\u00fcresel biyofarma m\u00fc\u015fterileriyle \u00e7ok say\u0131da b\u00fcy\u00fck \u00f6l\u00e7ekli yenileme<\/li>\n<li><strong>Sekt\u00f6r Trendi<\/strong>: D\u0131\u015f kaynakl\u0131 ara\u015ft\u0131rmalar y\u0131ll\u0131k %8 b\u00fcy\u00fcyor, \u00e7\u00fcnk\u00fc ila\u00e7 \u015firketleri maliyetleri k\u0131s\u0131yor<\/li>\n<li><strong>Dijital D\u00f6n\u00fc\u015f\u00fcm<\/strong>: Laboratuvar otomasyonu yat\u0131r\u0131mlar\u0131 marjlar\u0131 iyile\u015ftiriyor<\/li>\n<li><strong>Savunmac\u0131 \u0130\u015f Modeli<\/strong>: Ekonomik ko\u015fullardan ba\u011f\u0131ms\u0131z olarak temel hizmetler<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Son Haberlerin Etkisi: A\u011fustos 2025 Analizi<\/h2>\n<p>Charles River 2025&#8217;te olduk\u00e7a hareketli! \u015eirket, geli\u015fmi\u015f ila\u00e7 geli\u015ftirme modelleri geli\u015ftirmek i\u00e7in \u00f6nde gelen bir biyoteknoloji firmas\u0131yla geni\u015fletilmi\u015f i\u015f birli\u011fi dahil olmak \u00fczere birka\u00e7 stratejik ortakl\u0131k sa\u011flad\u0131. Bu anla\u015fmalar sadece bas\u0131n b\u00fclteni de\u011fil\u2014y\u0131llarca b\u00fcy\u00fcmeyi destekleyebilecek gelecekteki gelir ak\u0131\u015flar\u0131n\u0131 temsil ediyor.<\/p>\n<p>En \u00f6nemlisi, y\u00f6netim makroekonomik zorluklara ra\u011fmen tam y\u0131l rehberli\u011fini teyit etti. Y\u00f6neticiler belirsiz zamanlarda tahminlerinin arkas\u0131nda durdu\u011funda, bu genellikle iyi bir i\u015farettir.<\/p>\n<h2>\ud83c\udfaf Yeni Ba\u015flayanlar \u0130\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: A\u015f\u0131r\u0131 maruz kalmadan oyuna girmek i\u00e7in 1-2 hisse al\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Fiyat dalgalanmalar\u0131na bakmadan ayl\u0131k 100 $ ekleyin<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Hisse 150 $ destek seviyesine d\u00fc\u015ferse daha fazla al\u0131n<\/li>\n<li><strong>Sab\u0131r \u00d6d\u00fcllendirir<\/strong>: Bu 3-5 y\u0131ll\u0131k bir yat\u0131r\u0131m, haftal\u0131k ticaret de\u011fil<\/li>\n<li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: &#8220;CRL ticareti, boya kurumas\u0131n\u0131 izlemek gibidir\u2014ta ki aniden bir ba\u015fyap\u0131t olana kadar. At\u0131\u015ft\u0131rmal\u0131k getirin.&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ticaret Platformu Se\u00e7in<\/td>\n<td>NYSE hisseleri ve kesirli paylar sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Denemek i\u00e7in 50-100 $ ile ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;CRL&#8221; Aray\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Daha iyi giri\u015f i\u00e7in 158-161 $ civar\u0131nda limit emri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Ger\u00e7ekle\u015ftirin<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin\u2014%1&#8217;in alt\u0131nda i\u015flem maliyeti hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Portf\u00f6y Da\u011f\u0131l\u0131m\u0131n\u0131 Ayarlay\u0131n<\/td>\n<td>\u00c7e\u015fitlendirme i\u00e7in CRL&#8217;yi toplam portf\u00f6y\u00fcn %5-10&#8217;u aras\u0131nda tutun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Fiyat Uyar\u0131lar\u0131n\u0131 Etkinle\u015ftirin<\/td>\n<td>\u00d6nemli destek\/diren\u00e7 seviyelerinde bildirim al\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Tezinizi Belgeleyin<\/td>\n<td>Gelecek referans i\u00e7in neden ald\u0131\u011f\u0131n\u0131z\u0131 yaz\u0131n<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>D\u00fczenli \u0130nceleme Yap\u0131n<\/td>\n<td>G\u00fcnl\u00fck fiyat hareketleri de\u011fil, \u00e7eyreklik kazan\u00e7lar\u0131 kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Temett\u00fcleri Yeniden Yat\u0131r\u0131n<\/td>\n<td>CRL temett\u00fc \u00f6demez, ancak bile\u015fik b\u00fcy\u00fcme planlay\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option, CRL Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Neden Mant\u0131kl\u0131?<\/h2>\n<p>Pocket Option, Charles River Laboratories yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> &#8211; K\u00fc\u00e7\u00fck pozisyonlarla stratejileri test etmek i\u00e7in ideal<\/li>\n<li><strong>Y\u0131ld\u0131r\u0131m H\u0131z\u0131nda KYC<\/strong> &#8211; Herhangi bir kimlik belgesini y\u00fckleyin ve dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>100+ Para \u00c7ekme Y\u00f6ntemi<\/strong> &#8211; Kripto, e-c\u00fczdanlar, banka kartlar\u0131\u2014k\u00e2r\u0131n\u0131z, sizin se\u00e7iminiz<\/li>\n<li><strong>Kesirli Hisseler Mevcut<\/strong> &#8211; CRL&#8217;nin tam hisse fiyat\u0131 olmadan par\u00e7alar\u0131n\u0131 sat\u0131n al\u0131n<\/li>\n<li><strong>Ger\u00e7ek Zamanl\u0131 NYSE Verisi<\/strong> &#8211; Bilin\u00e7li kararlar i\u00e7in do\u011fru fiyatland\u0131rma<\/li>\n<\/ul>\n<p>Yeni yat\u0131r\u0131mc\u0131lar i\u00e7in bu eri\u015filebilirlik, binlerce dolar \u00f6nceden gerekmeden CRL&#8217;de kademeli pozisyon olu\u015fturman\u0131z\u0131 sa\u011flar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Charles River Laboratories: G\u00f6r\u00fcnmez \u0130la\u00e7 Devi<\/h2>\n<p>Charles River, herkesin bildi\u011fi bir isim de\u011fil ama olmal\u0131. Bu \u015firket, son be\u015f y\u0131lda <strong>FDA onayl\u0131 ila\u00e7lar\u0131n %80&#8217;inde<\/strong> yer ald\u0131\u2014bu, hastalara ula\u015fan hemen hemen her b\u00fcy\u00fck ila\u00e7 demek. 1947&#8217;de kurulan CRL, hayvan ara\u015ft\u0131rma sa\u011flay\u0131c\u0131s\u0131ndan, d\u00fcnya \u00e7ap\u0131nda ila\u00e7 devlerine hizmet veren kapsaml\u0131 bir ila\u00e7 geli\u015ftirme orta\u011f\u0131na evrildi.<\/p>\n<p>\u015eirket \u00fc\u00e7 ana segmentte faaliyet g\u00f6steriyor: Ara\u015ft\u0131rma Modelleri ve Hizmetleri, Ke\u015fif ve G\u00fcvenlik De\u011ferlendirmesi ve \u00dcretim Deste\u011fi. 20.100 \u00e7al\u0131\u015fan\u0131, kanserden nadir hastal\u0131klara kadar tedavileri h\u0131zland\u0131rmak i\u00e7in k\u00fcresel laboratuvarlarda \u00e7al\u0131\u015f\u0131yor.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Charles River&#8217;\u0131n bilim insanlar\u0131, bile\u015fik etkinli\u011fini %92 do\u011frulukla tahmin edebilen yapay zeka destekli \u00e7\u0131\u011f\u0131r a\u00e7an bir ila\u00e7 ke\u015fif platformu geli\u015ftirdi\u2014ara\u015ft\u0131rma s\u00fcresini y\u0131llardan aylara indiriyor ve geli\u015ftirme maliyetlerinde milyarlarca dolar tasarruf potansiyeli sunuyor.<\/p>\n"},"faq":[{"question":"Charles River Laboratories hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CRL\" sembol\u00fc ile arama yap\u0131n, uygun emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi ger\u00e7ekle\u015ftirin."},{"question":"CRL hisselerinin riskleri nelerdir?","answer":"D\u00fczenleyici de\u011fi\u015fiklikler, m\u00fc\u015fteri konsantrasyonu, d\u00f6viz kuru dalgalanmalar\u0131 ve y\u00fcksek bor\u00e7 seviyesi ba\u015fl\u0131ca risklerdir."},{"question":"CRL hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 175-190 $, 2026'da 200-225 $, 2028'de 280-320 $ ve 2030'da 400-450 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"CRL hisseleri uzun vadeli yat\u0131r\u0131m i\u00e7in uygun mu?","answer":"Evet, g\u00fc\u00e7l\u00fc kazan\u00e7 performans\u0131 ve b\u00fcy\u00fcme potansiyeli nedeniyle uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in g\u00fc\u00e7l\u00fc al\u0131m \u00f6nerilmektedir."},{"question":"Pocket Option CRL yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden avantajl\u0131d\u0131r?","answer":"D\u00fc\u015f\u00fck minimum yat\u0131r\u0131m, h\u0131zl\u0131 KYC, \u00e7oklu para \u00e7ekme y\u00f6ntemleri, kesirli hisse al\u0131m\u0131 ve ger\u00e7ek zamanl\u0131 NYSE verisi gibi avantajlar sunar."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Charles River Laboratories hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CRL\" sembol\u00fc ile arama yap\u0131n, uygun emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi ger\u00e7ekle\u015ftirin."},{"question":"CRL hisselerinin riskleri nelerdir?","answer":"D\u00fczenleyici de\u011fi\u015fiklikler, m\u00fc\u015fteri konsantrasyonu, d\u00f6viz kuru dalgalanmalar\u0131 ve y\u00fcksek bor\u00e7 seviyesi ba\u015fl\u0131ca risklerdir."},{"question":"CRL hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 175-190 $, 2026'da 200-225 $, 2028'de 280-320 $ ve 2030'da 400-450 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"CRL hisseleri uzun vadeli yat\u0131r\u0131m i\u00e7in uygun mu?","answer":"Evet, g\u00fc\u00e7l\u00fc kazan\u00e7 performans\u0131 ve b\u00fcy\u00fcme potansiyeli nedeniyle uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in g\u00fc\u00e7l\u00fc al\u0131m \u00f6nerilmektedir."},{"question":"Pocket Option CRL yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden avantajl\u0131d\u0131r?","answer":"D\u00fc\u015f\u00fck minimum yat\u0131r\u0131m, h\u0131zl\u0131 KYC, \u00e7oklu para \u00e7ekme y\u00f6ntemleri, kesirli hisse al\u0131m\u0131 ve ger\u00e7ek zamanl\u0131 NYSE verisi gibi avantajlar sunar."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T10:35:23+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T10:35:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\"},\"wordCount\":25,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\",\"name\":\"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-28T10:35:23+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","og_locale":"tr_TR","og_type":"article","og_title":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T10:35:23+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T10:35:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"wordCount":25,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","name":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-28T10:35:23+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354043,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Charles River Laboratories International, Inc. (CRL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"pt_AA":{"locale":"pt_AA","id":354040,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"Como comprar a\u00e7\u00f5es da Charles River Laboratories International, Inc. (CRL) - Investimento em a\u00e7\u00f5es da Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354038"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354038\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}